Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_assertion type Assertion NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_head.
- NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_provenance.
- NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_assertion evidence source_evidence_literature NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_provenance.
- NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_assertion SIO_000772 10690551 NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_provenance.
- NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_assertion wasDerivedFrom befree-20140225 NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_provenance.
- NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_assertion wasGeneratedBy ECO_0000203 NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_provenance.